• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926238350
Device Problems Occlusion Within Device (1423); Activation, Positioning or Separation Problem (2906)
Patient Problem Thrombosis (2100)
Event Date 12/13/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that stent inadequate expansion and stent thrombosis occurred.In (b)(6) 2017, the patient presented for percutaneous coronary intervention (pci).The 90% stenosed, 60mm in length, de novo target lesion was located in the calcified, 4.5mm in diameter, with 4mm minimum lumen diameter proximal to mid right coronary artery (rca).After a guide wire was inserted, an imaging catheter was advanced, but failed to cross the lesion.After pre-dilation was performed, intravascular ultrasound (ivus) and kissing balloon technique were performed on the bifurcation with rt branch.A 2.50 x 16 synergy¿ drug-eluting stent was then deployed at 16 atmospheres to treat the lesion.However, ivus result revealed that there was a part of incomplete expansion, so post-dilatation was performed.Subsequently, a non-bsc stent was deployed in distal of mid rca with 75% stenosis.It was overlapped about 1-2mm with the synergy stent.Residual stenosis was 0% with timi flow 3.In (b)(6) 2018, suspected stent thrombosis was reported and pci was performed.After a failed attempt to aspirate, balloon expansion was performed and the result was good.The procedure was completed.Residual stenosis was 25% and the patient condition was stable.
 
Manufacturer Narrative
Describe event or problem updated.Upn- search corrected from h7493926216250 - synergy ous mr 2.50 x 16 - 39262-1625 to h7493926238350 - synergy ous mr 3.50 x 38 - 39262-3835 upn corrected from h7493926216250 to h7493926238350.Catalog/model # corrected from 39262-1625 to 39262-3835.(b)(4).
 
Event Description
It was further reported that it was a 3.50 x 38 synergy¿ drug-eluting stent that was implanted in proximal to mid right coronary artery and not a 2.50 x 16 synergy¿ as the latter was never been used in the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7425814
MDR Text Key105303759
Report Number2134265-2018-02923
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 03/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberH7493926238350
Device Catalogue Number39262-3835
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/20/2018
Initial Date FDA Received04/12/2018
Supplement Dates Manufacturer Received03/20/2018
Supplement Dates FDA Received04/16/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STENT: ONYX; STENT: ONYX
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient Weight57
-
-